You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Merck
McKinsey
Mallinckrodt

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

LOPURIN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Lopurin patents expire, and what generic alternatives are available?

Lopurin is a drug marketed by Abbott and Dr Reddys La and is included in three NDAs.

The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the allopurinol profile page.

US ANDA Litigation and Generic Entry Outlook for Lopurin

A generic version of LOPURIN was approved as allopurinol by WATSON LABS on September 28th, 1984.

  Start Trial

Drug patent expirations by year for LOPURIN
Recent Clinical Trials for LOPURIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AbbViePhase 2
M.D. Anderson Cancer CenterPhase 2

See all LOPURIN clinical trials

Pharmacology for LOPURIN

US Patents and Regulatory Information for LOPURIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott LOPURIN allopurinol TABLET;ORAL 018297-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys La LOPURIN allopurinol TABLET;ORAL 071587-001 Apr 2, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
Abbott LOPURIN allopurinol TABLET;ORAL 018297-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys La LOPURIN allopurinol TABLET;ORAL 071586-001 Apr 2, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Merck
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.